1. Home
  2. MCFT vs DRUG Comparison

MCFT vs DRUG Comparison

Compare MCFT & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCFT
  • DRUG
  • Stock Information
  • Founded
  • MCFT 1968
  • DRUG 2019
  • Country
  • MCFT United States
  • DRUG United States
  • Employees
  • MCFT N/A
  • DRUG N/A
  • Industry
  • MCFT Marine Transportation
  • DRUG Pharmaceuticals and Biotechnology
  • Sector
  • MCFT Industrials
  • DRUG Health Care
  • Exchange
  • MCFT Nasdaq
  • DRUG Nasdaq
  • Market Cap
  • MCFT 303.7M
  • DRUG 260.6M
  • IPO Year
  • MCFT 2015
  • DRUG N/A
  • Fundamental
  • Price
  • MCFT $18.10
  • DRUG $35.99
  • Analyst Decision
  • MCFT Buy
  • DRUG Strong Buy
  • Analyst Count
  • MCFT 4
  • DRUG 4
  • Target Price
  • MCFT $20.50
  • DRUG $84.33
  • AVG Volume (30 Days)
  • MCFT 76.1K
  • DRUG 69.2K
  • Earning Date
  • MCFT 02-06-2025
  • DRUG 03-04-2025
  • Dividend Yield
  • MCFT N/A
  • DRUG N/A
  • EPS Growth
  • MCFT N/A
  • DRUG N/A
  • EPS
  • MCFT N/A
  • DRUG N/A
  • Revenue
  • MCFT $311,260,000.00
  • DRUG N/A
  • Revenue This Year
  • MCFT N/A
  • DRUG N/A
  • Revenue Next Year
  • MCFT $16.63
  • DRUG N/A
  • P/E Ratio
  • MCFT N/A
  • DRUG N/A
  • Revenue Growth
  • MCFT N/A
  • DRUG N/A
  • 52 Week Low
  • MCFT $16.12
  • DRUG $0.93
  • 52 Week High
  • MCFT $24.05
  • DRUG $79.02
  • Technical
  • Relative Strength Index (RSI)
  • MCFT 43.48
  • DRUG 43.58
  • Support Level
  • MCFT $18.45
  • DRUG $40.10
  • Resistance Level
  • MCFT $19.51
  • DRUG $47.50
  • Average True Range (ATR)
  • MCFT 0.78
  • DRUG 3.56
  • MACD
  • MCFT -0.09
  • DRUG -0.51
  • Stochastic Oscillator
  • MCFT 14.55
  • DRUG 23.22

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: